Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 91.45
-0.05 (-0.05%)
Apr 20, 2026, 3:23 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 158.08 billion as of April 20, 2026. Its market cap has increased by 146.47% in one year.
Market Cap
158.08B
Enterprise Value
140.92B
Revenue
14.51B
Ranking
n/a
PE Ratio
174.18
Stock Price
91.45
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 158.08B, an increase of 752.67%. That is a compound annual growth rate of 33.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 158.08B | 19.51% |
| Dec 31, 2025 | 132.27B | 120.60% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.22B |
| WuXi Biologics | 147.80B |
| Akeso | 139.09B |
| Sichuan Kelun-Biotech Biopharmaceutical | 121.26B |
| Sino Biopharmaceutical | 107.21B |
| RemeGen | 85.82B |
| 3SBio | 63.09B |
| Shanghai Junshi Biosciences | 47.19B |